Pastor-Quirós LJ, Correa-Díaz EP. The budgetary impact of alemtuzumab in multiple sclerosis in Quito, Ecuador. Payer’s perspective. Grhta [Internet]. 2021 Oct. 21 [cited 2024 Apr. 19];8(1):140-6. Available from: https://journals.aboutscience.eu/index.php/grhta/article/view/2273